Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024and expands access to patients and caregivers managing Type 1 Allergic Reactions. SAN D ...
has added neffy ® (epinephrine nasal spray) to its Commercial national formularies. This decision makes neffy broadly available to millions of their commercially insured patients across the country.
(epinephrine nasal spray) to its Commercial national formularies. This decision makes neffy broadly available to millions of their commercially insured patients across the country. neffy 2 mg is for ...
“The inclusion of neffy on Express Scripts’ Commercial National Formularies significantly improves access to life-saving allergy treatment,” said Sal Grausso, Head of Market Access at ARS ...